BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rajan P, Iglay K, Rhodes T, Girman CJ, Bennett D, Kalantar-Zadeh K. Risk of bias in non-randomized observational studies assessing the relationship between proton-pump inhibitors and adverse kidney outcomes: a systematic review. Therap Adv Gastroenterol 2022;15:17562848221074183. [PMID: 35173802 DOI: 10.1177/17562848221074183] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Pannoi T, Promchai C, Apiromruck P, Wongpraphairot S, Yang C, Pan W. Estimates of Chronic Kidney Diseases Associated with Proton-Pump Inhibitors Using a Retrospective Hospital-Based Cohort in Thailand. IJNRD 2022;Volume 15:371-381. [DOI: 10.2147/ijnrd.s389238] [Reference Citation Analysis]
2 Wakai E, Ikemura K, Mizuno T, Takeuchi K, Tamaru S, Okuda M, Nishimura Y. Repositioning of Lansoprazole as a Protective Agent Against Cisplatin-Induced Ototoxicity. Front Pharmacol 2022;13:896760. [DOI: 10.3389/fphar.2022.896760] [Reference Citation Analysis]